Canada markets close in 5 hours 21 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.0701+0.0101 (+0.49%)
As of 10:39AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 233.81M
Enterprise Value 596.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.75
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.32
Enterprise Value/EBITDA -3.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 3-71.86%
S&P500 52-Week Change 323.57%
52 Week High 38.2200
52 Week Low 31.4300
50-Day Moving Average 32.2904
200-Day Moving Average 33.0763

Share Statistics

Avg Vol (3 month) 32.46M
Avg Vol (10 day) 31.48M
Shares Outstanding 5113.5M
Implied Shares Outstanding 6113.5M
Float 8103.87M
% Held by Insiders 11.41%
% Held by Institutions 177.33%
Shares Short (Apr 15, 2024) 421.53M
Short Ratio (Apr 15, 2024) 48.97
Short % of Float (Apr 15, 2024) 422.20%
Short % of Shares Outstanding (Apr 15, 2024) 418.97%
Shares Short (prior month Mar 15, 2024) 425.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -92.48%
Operating Margin (ttm)-98.78%

Management Effectiveness

Return on Assets (ttm)-21.75%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)257.24M
Revenue Per Share (ttm)2.73
Quarterly Revenue Growth (yoy)101.80%
Gross Profit (ttm)N/A
EBITDA -189.41M
Net Income Avi to Common (ttm)-237.89M
Diluted EPS (ttm)-2.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)117.75M
Total Cash Per Share (mrq)1.04
Total Debt (mrq)480.84M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.43
Book Value Per Share (mrq)-1.72

Cash Flow Statement

Operating Cash Flow (ttm)-174.88M
Levered Free Cash Flow (ttm)-70.1M